Page de couverture de The Line

The Line

The Line

Auteur(s): Matt Gurney and Jen Gerson
Écouter gratuitement

À propos de cet audio

The Line is a Canadian magazine dedicated to covering local, national and international politics, news, current events and occasionally some obscure stories. Hosted by Matt Gurney and Jen Gerson.

© 2026 The Line
Politique
Épisodes
  • Carney sticks it to Putin ... but will food prices sink him?
    Nov 17 2026

    In this episode of On The Line, host Matt Gurney is joined by two guests to discuss hockey, inflation, politics, and whether Canada can finally get serious about building major infrastructure.

    This episode is brought to you by BioCanRx. We've been partnering with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Canada immunotherapies offer new ways to beat cancer. This month we’re addressing common questions, like: do these therapies have export potential?

    The farthest advanced BioCanRx-supported therapies are still in clinical trials here in Canada, but other countries are already expressing interest based on their efficacy and lower cost. Canadian-developed CAR-T technology from the CLIC group is already being used to treat clinical trial patients in Denmark, and other countries with high numbers of leukemia cases have expressed interest. A successful clinical trial in another country can be an important first step toward bringing that therapy to market there. If BioCanRx-supported therapies continue to be trialed outside Canada, it sends a strong signal that made-in-Canada immunotherapies will find a receptive international market.

    Thanks to BioCanRx for continuing to partner with The Line to share this information. Visit BioCanRx.com to learn more.


    First up is Scott Stinson, a contributor to The Line and columnist with the National Post. In theory, Matt and Scott are here to talk about hockey, and how prime minister Mark Carney has been using Canada's national game as an instrument of geopolitical power — with some success so far. And they do talk about that! But breaking news intrudes on their plans to have a more relaxed episode, with new inflation numbers coming in hotter than expected. Rising gasoline prices are part of the story, so this isn't a shock, but Matt and Scott discuss the bigger political problem facing Carney. As the immediate threat from Donald Trump (maybe) begins to recede, Canadians are increasingly focused on the cost of living. What happens to Carney's political fortunes when voters stop worrying quite so much about Trump and start wondering why everything has become so expensive?

    The episode is also brought to you by the Forest Products Association of Canada. For years, the Forest Products Association of Canada has called for action to reduce regulatory duplication and create greater certainty for mills, factories, and investment. We’re encouraged to see the federal government taking action to make Canada’s regulatory system more coordinated and predictable, removing made-in-Canada barriers that have held the sector back. This is an important step for forestry and for communities across the country that depend on the sector.

    Now, we need to move from promises to production. Canadian jobs, stronger supply chains, and new opportunities for communities from coast to coast to coast depend on it.

    Canada’s forest sector is ready to do its part. Learn more at FPAC.ca.

    Then Matt is joined by Alan Finlay, The Line's newest hire and first-ever reporter. Alan is spending the next year investigating what works, what doesn't, and why Canada has such a difficult time getting big things done. His first story, published just a few days ago, examines ALTO, the proposed high-speed rail system. Alan walks Matt through what he learned while reporting the piece, including the biggest threats facing the project, the obstacles that could derail it, and some surprisingly encouraging signs that Canada might actually get this one right.

    This episode is also brought to you by Cameco. Building Canada’s energy future means creating jobs for Canadian workers. That’s why the AP1000 reactor is the right choice for Canada: it is already operating and ready to deliver the power we need. Choosing the AP1000 means a reactor built by Canadians, creating skilled jobs in construction, fabrication and the trades while keeping more investment and economic benefits here at home. If we are serious about creating Canadian jobs and strengthening our economy, the choice is clear. To learn more, visit ap1000.cameco.com.


    Be sure to check out Alan's reporting, along with all of our other great content, at Readtheline.ca. Like and subscribe!

    #OnTheLine #MattGurney #ScottStinson #AlanFinlay #MarkCarney #CanadaPolitics #CanadianEconomy #Inflation #CostOfLiving #CanadianHockey #HighSpeedRail #ALTO #Infrastructure #BuildCanada

    Voir plus Voir moins
    1 h et 8 min
  • Carney's Immigration Fail
    Nov 13 2026

    In the latest episode of The Line Podcast, recorded on November 13th, 2026, Matt Gurney is joined by Andrew Potter, filling in for Jen Gerson from Montreal.

    This episode is brought to you by Cameco. Building Canada’s energy future means creating jobs for Canadian workers. That’s why the AP1000 reactor is the right choice for Canada: it is already operating and ready to deliver the power we need. Choosing the AP1000 means a reactor built by Canadians, creating skilled jobs in construction, fabrication and the trades while keeping more investment and economic benefits here at home. If we are serious about creating Canadian jobs and strengthening our economy, the choice is clear. To learn more, visit ap1000.cameco.com.


    First up, your hosts tackle the immigration debate now exploding across Canada. Both are very mindful of the fact that they're middle-aged white dudes, but they have serious concerns about the government's new proposals. For one thing, the economic rationale simply isn't there. For another, the Liberals have done almost none of the political groundwork necessary to sell these changes to Canadians. As Andrew notes, this government, like most Liberal governments, hates having to explain itself to the public. Matt worries that the consequences could be severe. Canada has maintained a remarkable pro-immigrant consensus for decades, and while Canadians have clearly soured on immigration, they haven't yet soured on immigrants. That distinction matters. And it might not last.

    Next, Matt and Andrew turn to the war in Ukraine, where Russia is hammering the country's utilities and forcing Ukrainians into darkness and cold as winter approaches. Matt also highlights a series of particularly brutal recent terror attacks against Ukrainian civilians, attacks that serve no military purpose beyond demoralizing the population. Your hosts agree that Vladimir Putin is trying to force some kind of resolution of the war before the Democrats take control of the U.S. Congress in January. Matt wonders whether Ukraine can hold out that long. Andrew has another question: even if it can, what help is actually coming? Will the Democrats care? Will the Europeans finally step up?

    This episode is also brought to you by BioCanRx. We've been partnering with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Canada immunotherapies offer new ways to beat cancer. This week we asked whether the new federal budget improves the landscape for Canadian drug development. Short answer: it does! New tax incentives will support Canadian biotech companies carrying out commercialization and regulatory activities in Canada, and federal research funding agencies will modernize to offer additional support for bridging lab to market. The government also pledged to respond to recommendations from last summer’s Pharmaceutical and Life Sciences Sector Task Force. Steps like these can address key challenges facing Canada's life-sciences sector and make Canada more globally competitive. There is much more work to do to support Canadian health-care systems. BioCanRx will continue to participate in any effort to strengthen Canada's life-sciences ecosystem and help Canadian discoveries become therapies to treat patients across Canada and the world. Thanks to them for continuing to partner with The Line to share this information. Visit BioCanRx.com to learn more.


    Finally, your hosts discuss the rapid downfall of Nvidia's Jensen Huang following revelations of a series of extramarital affairs with employees and potentially a Chinese intelligence asset. But the conversation quickly broadens to the extraordinary pace of progress in artificial intelligence, the threats this technology may pose to human civilization, and the difficulty of imagining any government effectively regulating it. Matt and Andrew consider historical parallels with genetic engineering and thermonuclear weapons, and the uncomfortable reality that AI has become one of those rare technologies where the people who understand it best, and who are actually responsible for creating it, often seem the most terrified of what they're unleashing.

    Maybe we should think about that.

    All that and more in the latest episode of The Line Podcast. Check out our main page at ReadTheLine.ca and remember to like and subscribe before your AI does it for you.

    #TheLinePodcast #CanadianImmigration #MarkCarney #CanadianPolitics #UkraineWar #VladimirPutin #ArtificialIntelligence #Nvidia #JensenHuang #AISafety

    Voir plus Voir moins
    1 h et 7 min
  • How Canada will fight, and who we'll let in
    Nov 10 2026
    In this episode of On The Line, host Matt Gurney is joined by two guests to discuss what the federal budget tells us about Canada's plans for national defence, immigration, housing and the economy.This episode is brought to you by BioCanRx. We've been partnering with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Canada immunotherapies offer new ways to beat cancer. This week we asked whether the new federal budget improves the landscape for Canadian drug development. Short answer: it does!New tax incentives will support Canadian biotech companies carrying out commercialization and regulatory activities in Canada, and federal research funding agencies will modernize to offer additional support for bridging lab to market. The government also pledged to respond to recommendations from last summer’s Pharmaceutical and Life Sciences Sector Task Force. Steps like these can address key challenges facing Canada's life-sciences sector and make Canada more globally competitive.There is much more work to do to support Canadian health-care systems. BioCanRx will continue to participate in any effort to strengthen Canada's life-sciences ecosystem and help Canadian discoveries become therapies to treat patients across Canada and the world. Thanks to them for continuing to partner with The Line to share this information. Visit BioCanRx.com to learn more.First up is Philippe Lagassé, a defence expert at Carleton University, who joins Matt to examine the budget's national security commitments. How much is Canada actually spending on defence, and how sustainable is that spending? Lagassé explains why the government's plans may be more financially realistic than previously thought, provided spending stays within certain limits. But unexpected events have a way of disrupting even the best-laid plans, especially in an increasingly dangerous world.Matt and Phil also discuss the proposed funding increase for Canadian intelligence agencies. What problems is the government trying to solve, and what capabilities does Canada need to develop? And, finally, a question for the military procurement enthusiasts: are we actually going to get a Canadian MI6?The episode is also brought to you by the Forest Products Association of Canada.For years, the Forest Products Association of Canada has called for action to reduce regulatory duplication and create greater certainty for mills, factories, and investment.We’re encouraged to see the federal government taking action to make Canada’s regulatory system more coordinated and predictable, removing made-in-Canada barriers that have held the sector back. This is an important step for forestry and for communities across the country that depend on the sector.Now, we need to move from promises to production. Canadian jobs, stronger supply chains, and new opportunities for communities from coast to coast to coast depend on it.Canada’s forest sector is ready to do its part. Learn more at FPAC.ca.Then Matt is joined by economist Mike Moffatt of the Missing Middle Initiative to discuss some surprising immigration numbers buried in the budget. There's the official immigration target, and then there's what amounts to a second, much larger shadow target. Why is the government planning for so many more people than the headline numbers suggest?Moffatt explains that there's a legitimate policy rationale behind the approach, but also a much more troubling problem: Canada has built structural dependencies into its immigration system that are increasingly difficult to unwind without making those arrangements permanent. Matt and Mike discuss the risks of continuing without a coherent long-term strategy, and why Canada urgently needs to think beyond annual immigration targets and start planning for the country it actually intends to build.This episode is also brought to you by Cameco. Building Canada’s energy future means creating jobs for Canadian workers. That’s why the AP1000 reactor is the right choice for Canada: it is already operating and ready to deliver the power we need. Choosing the AP1000 means a reactor built by Canadians, creating skilled jobs in construction, fabrication and the trades while keeping more investment and economic benefits here at home. If we are serious about creating Canadian jobs and strengthening our economy, the choice is clear. To learn more, visit ap1000.cameco.com.Check out our main page at ReadTheLine.ca. Like and subscribe!#OnTheLine #CanadaPolitics #Budget2026 #CanadianMilitary #DefenceSpending #NationalSecurity #CanadianIntelligence #Immigration #ImmigrationPolicy #HousingCrisis #PhilippeLagasse #MikeMoffatt #MattGurney
    Voir plus Voir moins
    53 min
adbl_web_anon_alc_button_suppression_t1
Pas encore de commentaire